Literature DB >> 11104662

CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.

H A Phillips1, I Favre, M Kirkpatrick, S M Zuberi, D Goudie, S E Heron, I E Scheffer, G R Sutherland, S F Berkovic, D Bertrand, J C Mulley.   

Abstract

Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is an uncommon, idiopathic partial epilepsy characterized by clusters of motor seizures occurring in sleep. We describe a mutation of the beta2 subunit of the nicotinic acetylcholine receptor, effecting a V287M substitution within the M2 domain. The mutation, in an evolutionary conserved region of CHRNB2, is associated with ADNFLE in a Scottish family. Functional receptors with the V287M mutation are highly expressed in Xenopus oocytes and characterized by an approximately 10-fold increase in acetylcholine sensitivity. CHRNB2 is a new gene for idiopathic epilepsy, the second acetylcholine receptor subunit implicated in ADNFLE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104662      PMCID: PMC1234917          DOI: 10.1086/316946

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  A de novo mutation in sporadic nocturnal frontal lobe epilepsy.

Authors:  H A Phillips; C Marini; I E Scheffer; G R Sutherland; J C Mulley; S F Berkovic
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure.

Authors:  R Anand; W G Conroy; R Schoepfer; P Whiting; J Lindstrom
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.

Authors:  E Cooper; S Couturier; M Ballivet
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

Review 4.  Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Authors:  A Devillers-Thiéry; J L Galzi; J L Eiselé; S Bertrand; D Bertrand; J P Changeux
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

5.  Molecular cloning of a human neuronal nicotinic acetylcholine receptor beta 3-like subunit.

Authors:  J J Willoughby; N N Ninkina; M M Beech; D S Latchman; J N Wood
Journal:  Neurosci Lett       Date:  1993-06-11       Impact factor: 3.046

6.  Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy.

Authors:  O K Steinlein; J Stoodt; J Mulley; S Berkovic; I E Scheffer; E Brodtkorb
Journal:  Epilepsia       Date:  2000-05       Impact factor: 5.864

7.  Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene.

Authors:  A Sáenz; J Galán; C Caloustian; F Lorenzo; C Márquez; N Rodríguez; M D Jiménez; J J Poza; A M Cobo; D Grid; J F Prud'homme; A López de Munain
Journal:  Arch Neurol       Date:  1999-08

8.  A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  S Hirose; H Iwata; H Akiyoshi; K Kobayashi; M Ito; K Wada; S Kaneko; A Mitsudome
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

9.  A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction.

Authors:  R M Nelson; G L Long
Journal:  Anal Biochem       Date:  1989-07       Impact factor: 3.365

10.  The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy.

Authors:  M De Fusco; A Becchetti; A Patrignani; G Annesi; A Gambardella; A Quattrone; A Ballabio; E Wanke; G Casari
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

View more
  50 in total

Review 1.  Ion channels and neurology.

Authors:  S M Zuberi; M G Hanna
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

Review 2.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

3.  Search for alpha4 and alpha7 nicotinic acetylcholine receptor markers in a pedigree of benign familial infantile convulsions (BFIC).

Authors:  M B Rauschemberger; C Vecchi; F J Barrantes
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 4.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

5.  Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Zhihong Chen; Lingan Wang; Chun Wang; Qian Chen; Qiongxiang Zhai; Yuxiong Guo; Yuxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy.

Authors:  Agata Rozycka; Jolanta Dorszewska; Barbara Steinborn; Margarita Lianeri; Anna Winczewska-Wiktor; Aleksandra Sniezawska; Kamila Wisniewska; Pawel P Jagodzinski
Journal:  DNA Cell Biol       Date:  2013-09-11       Impact factor: 3.311

Review 7.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 8.  The sleep manifestations of frontal lobe epilepsy.

Authors:  Christopher P Derry
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

9.  Functional polymorphisms in the human beta4 subunit of nicotinic acetylcholine receptors.

Authors:  Yong Liang; Ramiro Salas; Lisa Marubio; Dani Bercovich; Mariella De Biasi; Arthur L Beaudet; John A Dani
Journal:  Neurogenetics       Date:  2004-11-25       Impact factor: 2.660

Review 10.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.